The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Chronic degenerative inflammatory diseases, such as chronic obstructive pulmonary disease and Alzheimer's dementia, afflict millions of people around the world, causing death and debilitation. Despite the global impact of these diseases, there have been few innovative breakthroughs into their cause, treatment or cure. As with many debilitating disorders, chronic degenerative inflammatory diseases may be associated with defective or dysfunctional responses to second messengers, such as cyclic adenosinemonophosphate (cAMP). The identification of the cAMP‐activated guanine nucleotide exchange factors for Ras‐like GTPases, Epac1 (also known as cAMP‐GEF‐I) and Epac2 (also known as cAMP‐GEF‐II), profoundly altered the prevailing assumptions concerning cAMP signalling, which until then had been solely associated with protein kinase A (PKA). Studies of the molecular mechanisms of Epac‐related signalling have demonstrated that these novel cAMP sensors regulate many physiological processes either alone and/or in concert with PKA. These include calcium handling, cardiac and smooth muscle contraction, learning and memory, cell proliferation and differentiation, apoptosis, and inflammation. The diverse signalling properties of cAMP might be explained by spatio‐temporal compartmentalization, as well as A‐kinase anchoring proteins, which seem to coordinate Epac signalling networks. Future research should focus on the Epac‐regulated dynamics of cAMP, and, hopefully, the development of compounds that specifically interfere with the Epac signalling system in order to determine the precise significance of Epac proteins in chronic degenerative inflammatory disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of microorganisms and activation of the immune response
Medzhitov, R. (2007) · Nature · doi:10.1038/nature06246 · Cited by 2,862 · cited 4×
“Mature lymphocytes with their antigen-specific receptors are in permanent circulation from the blood stream to the lymphoid organs, and represent the main mediators of the adaptive immune response (Vivier and Malissen, 2005; Medzhitov, 2007).”
BackgroundInfluentialIntegrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350 · cited 2×
“Further details on the molecular mechanisms of the regulation of Epac-related effectors and their biological functions are outlined in recent excellent reviews on these topics (Cohen and Frame, 2001; Scheid and Woodgett, 2001; Kolch, 2005; Bunney and Katan, 2006; Oude Weernink et al., 2007; Perkins, 2007; Schmierer an…”
BackgroundGEFs and GAPs: Critical Elements in the Control of Small G Proteins
Bos, J. L., Rehmann, H., & Wittinghofer, A. (2007) · Cell · doi:10.1016/j.cell.2007.05.018 · Cited by 1,903 · cited 1×
“Signalling of cAMP via cyclic nucleotide-gated channels, CNrasGEF and/or PSD-95/ DlgA/ZO-1 (PDZ)-GEF has been outlined in prior reviews (Bos et al., 2007; Biel and Michalakis, 2009; Biel, 2009; Pannekoek et al., 2009; Raaijmakers and Bos, 2009).”
MethodAsthma: From Bronchoconstriction to Airways Inflammation and Remodeling
BOUSQUET, J., JEFFERY, P. K., BUSSE, W. W., JOHNSON, M., & VIGNOLA, A. M. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9903102 · Cited by 1,702
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 2×
“Further details on the molecular mechanisms of the regulation of Epac-related effectors and their biological functions are outlined in recent excellent reviews on these topics (Cohen and Frame, 2001; Scheid and Woodgett, 2001; Kolch, 2005; Bunney and Katan, 2006; Oude Weernink et al., 2007; Perkins, 2007; Schmierer an…”
BackgroundRegulation of lung injury and repair by Toll-like receptors and hyaluronan
Jiang, D., Liang, J., Fan, J., Yu, S., Chen, S., Luo, Y., Prestwich, G. D., Mascarenhas, M. M., Garg, H. G., Quinn, D. A., et al. (2005) · Nature Medicine · doi:10.1038/nm1315 · Cited by 1,401
AKAP signalling complexes: focal points in space and time
Wong, W., & Scott, J. D. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1527 · Cited by 1,073 · cited 12×
“It is interesting to note that Epac proteins exert their diverse biological functions either alone and/or in concert with PKA, and that distinct cAMP signalling complexes seem to be coordinated by AKAPs, which are known to interact with PKA and PDEs (Wong and Scott, 2004; Gold et al., 2006; Kinderman et al., 2006; Bee…”
BackgroundInfluentialRas and Rap control AMPA receptor trafficking during synaptic plasticity
Zhu, J. J., Qin, Y., Zhao, M., Van Aelst, L., & Malinow, R. (2002) · Cell · doi:10.1016/s0092-8674(02)00897-8 · Cited by 769 · cited 1×
“It is worth noting that both PKA anchored to neuronal AKAP79/150 and the Epac effector Rap have been reported to regulate alpha-amino-3hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking during synaptic plasticity (Zhu et al., 2002, 2005; Snyder et al. 2005).”
BackgroundHyaluronan Fragments Act as an Endogenous Danger Signal by Engaging TLR2
Scheibner, K. A., Lutz, M. A., Boodoo, S., Fenton, M. J., Powell, J. D., & Horton, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.1272 · Cited by 708 · cited 2×
“It has also been reported that during inflammation, hyaluronan is degraded to lower molecular weight fragments that subsequently stimulate macrophages and airway epithelial cells to produce mediators of tissue injury and repair, including TNF-a, interleukin (IL)-12, macrophage inflammatory protein (MIP)1a, MIP-2, IL-8…”
BackgroundcAMP-GEFII is a direct target of cAMP in regulated exocytosis
Ozaki, N., Shibasaki, T., Kashima, Y., Miki, T., Takahashi, K., Ueno, H., Sunaga, Y., Yano, H., Matsuura, Y., Iwanaga, T., et al. (2000) · Nature Cell Biology · doi:10.1038/35041046 · Cited by 481 · cited 2×
“Epac2 is localized to the (sub)plasma membrane, cytosolic fractions, actin cytoskeleton, meiotic midzone region and Golgi in several cells, such as MIN6, pancreatic islets, H1299, human microvascular endothelial cells, different tubular segmental cells of rat (human) kidney, rat cholangiocytes, adult rat ventricular m…”
Background
Cited by
Keravis, T., & Lugnier, C. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01729.x · Cited by 385
Schmidt, M., Dekker, F. J., & Maarsingh, H. (2013) · Pharmacological Reviews · doi:10.1124/pr.110.003707 · Cited by 267
Self-citationRegulation of aldosterone synthesis and secretion.
Bollag, W. B. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130037 · Cited by 180
cAMP and Epac in the regulation of tissue fibrosis
Insel, P. A., Murray, F., Yokoyama, U., Romano, S., Yun, H., Brown, L., Snead, A., Lu, D., & Aroonsakool, N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01847.x · Cited by 175
“452 British Journal of Pharmacology (2012) 166 447–456 Grandoch et al., 2010; Breckler et al., 2011; Mironov et al., 2011; Stokman et al., 2011). siRNA-mediated inhibition of Epac1 (but not Epac2) in rat cardiac fibroblasts and its downstream mediator Rap-1 decreases cAMP-induced migration of…”
BackgroundInfluentialColangelo, M. T., Galli, C., & Guizzardi, S. (2020) · Regenerative Medicine · doi:10.2217/rme-2019-0118 · Cited by 59
Metadata
- Authors
- Grandoch, M., Roscioni, S. S., & Schmidt, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 159
- Issue
- 2
- Pages
- 265-284
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1543612160
- Cited by
- 154
- References
- 17
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00458.x
- The paper
- Grandoch, M., Roscioni, S. S., & Schmidt, M. (2010). The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00458.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.